Table 3.
Antibody | Target | Dilution | Source |
---|---|---|---|
HECD-1 | E-cadherin | neat supernatant | ICRF |
α-catenin | α-catenin | 1:500 | Affinity (Nottingham, U.K.) |
β-catenin | β-catenin | 1:1000 | Affinity |
γ-catenin | γ-catenin | 1:1000 | Affinity |
Ali-28 | APC (N-terminal) | 1:50 | ICRF, ref. 20 |
PR1A3 | CEA | 1:1000 | ICRF, ref. 21 |
APC, antigen-presenting cell; CEA, carcinoembryonic antigen; ICRF, Imperial Cancer Research Fund.